Residual Disease Burden Among European Patients With Inflammatory Bowel Disease: A Real-World Survey.

ABSTRACT:

Background

Understanding disease burden is imperative for improving inflammatory bowel disease (IBD) management. This real-world survey investigated residual disease burden and treatment satisfaction among European patients with moderate-to-severe ulcerative colitis (UC) and Crohn's disease (CD).

Methods

The Adelphi Real World IBD Disease Specific Programme was a multinational, cross-sectional survey with retrospective collection of patient- and physician-reported data on disease burden and management. Between October 2020 and March 2021, participating gastroenterologists recruited their next 7 (UC) and 8 (CD) eligible patients and reported demographics and clinical characteristics. Patients completed symptom, health-related quality of life (HRQoL), and treatment satisfactio

SUBMITTER: Burisch J 

PROVIDER: S-EPMC11808571 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature